Results 111 to 120 of about 32,704 (143)
Quality control assessment of influenza and RSV testing in Europe: 2000-01 season
Martine Valette, M. Aymard
openalex +1 more source
Absence of antenatal immunity to respiratory syncytial virus (RSV) at birth
Subramaniam Krishnan+2 more
openalex +1 more source
Role of mucosal IFN-γ gene transfer on allergic sensitization and RSV infection
Mukesh Kumar+3 more
openalex +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
New England Journal of Medicine, 2023BACKGROUND Respiratory syncytial virus (RSV) infection causes considerable illness in older adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein-based (RSVpreF) vaccine in this population are unknown.
E. Walsh+30 more
semanticscholar +1 more source
RSV Epidemiology in Australia Before and During COVID-19.
Pediatrics, 2022BACKGROUND AND OBJECTIVES COVID-19 public health measures have altered respiratory syncytial virus (RSV) epidemiology, resulting in an unseasonal summer epidemic in Australia in 2020.
G. Saravanos+10 more
semanticscholar +1 more source
Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic
Pediatrics, 2021An unexpected positive outcome of the coronavirus disease 2019 pandemic has been the marked decline in illness associated with other respiratory viruses, likely due to the widespread use of masks and social distancing.
R. Agha, J. Avner
semanticscholar +1 more source
Predicting the RSV Surge: Pediatric RSV Patterns of the COVID Pandemic
Pediatric Infectious Disease Journal, 2023Historically, respiratory syncytial virus (RSV) infection trends have been predictable. The COVID-19 pandemic and associated precautions impacted RSV disease patterns. RSV infection trends during the first year of the COVID-19 pandemic may have predicted the 2022 surge in pediatric RSV infections.
Sidney Zven+5 more
openaire +2 more sources
Paediatric Respiratory Reviews, 2009
An economic analysis was performed in Spain to evaluate the efficiency (cost-effectiveness) of palivizumab in preventing severe RSV infection in premature infants with GA 32-35 and two or more risk factors (RF). The design was a decision tree model using data from the scientific literature and the FLIP I and FLIP II studies IRIS Study Group.
Pablo Lázaro y de Mercado+1 more
openaire +2 more sources
An economic analysis was performed in Spain to evaluate the efficiency (cost-effectiveness) of palivizumab in preventing severe RSV infection in premature infants with GA 32-35 and two or more risk factors (RF). The design was a decision tree model using data from the scientific literature and the FLIP I and FLIP II studies IRIS Study Group.
Pablo Lázaro y de Mercado+1 more
openaire +2 more sources
Comparative study of RSV rescue from RSV‐transformed mammalian cells [PDF]
AbstractAll individual heterokaryons obtained by fusion of cells of the five different mammalian RSV‐transformed virogenic cells with indicator chicken fibroblasts produced infectious RSV. In contrast, non‐virogenic mammalian cells derived from tumours which arose in mice injected with RSV did not give rise to infectious RSV, even when fused with ...
Vlasta Sovová+3 more
openaire +2 more sources